Abstract
We investigated the effect of a synthetic lipid A analogue with low endotoxicity, DT‐5461, on the neovascularization induced by B16‐BL6 melanoma in syngenelc mice. A systemic single administration of DT‐5461 caused a marked decrease in the number of vessels oriented toward the tumor mass and in the tumor size during the early phase of vasculogenesis (on day 4 after tumor inoculation), with little or no inhibition in the following phases. Multiple i.v. administrations of DT‐5461 at intervals of 4 days (an effective schedule for inhibiting tumor metastasis) significantly reduced the number of capillary vessels and tumor growth over a period of 14 days after the tumor implantation. Multiple systemic administrations of DT‐5461 on days 1, 5 and 9 after tumor inoculation caused a high production of endogenous tumor necrosis factor‐α (TNF‐α) in tumor sites although this treatment modality induced a low production in serum of tumor‐bearing mice. Tumor homogenate from mice treated with DT‐5461 suppressed the proliferation of endothelium in vitro, whereas sera from animals given DT‐5461 had little effect. Furthermore, the antiproliferative effect of the tumor homogenate from mice treated with DT‐5461, was completely abrogated by anti‐mTNF‐α monoclonal antibody (mAb). The anti‐angiogenic effect of DT‐5461 was also completely abrogated by rabbit anti‐mouse tumor necrosis factor‐α (anti‐mTNF‐α) antiserum, whereas the inhibition of tumor growth by DT‐5461 was only slightly diminished. Tumor homogenate from mice treated with DT‐5461 suppressed the proliferation of endothelium in vitro, whereas sera from animals given DT‐5461 had little effect. Furthermore, the antiproliferative effect of the tumor homogenate from mice treated with DT‐5461 was completely neutralized by anti‐mTNF‐α mAb. Multiple i.v. administrations of DT‐5461 after s.c. implantation of B16‐BL6 cells significantly inhibited the growth of primary tumors measured at the time of tumor excision on day 21, and the lung metastasis of melanoma cells as compared with the untreated control in the spontaneous metastasis model. These results suggested that the suppressive effect upon tumor‐associated angiogenesis by DT‐5461 contributes in part to the inhibition of tumor metastasis.
Keywords: Synthetic lipid A analogue, TNF‐α, Melanoma, Tumor‐induced angiogenesis, Lung metastasis
Full Text
The Full Text of this article is available as a PDF (832.4 KB).
REFERENCES
- 1).Knighton , D. R. , Silver , I. A. and Folkman , J.Regulation of wound healing angiogenesis. Effect of oxygen gradients in inspired oxygen concentration . Surgery , 90 , 262 – 270 ( 1981. ). [PubMed] [Google Scholar]
- 2).Gospodarowicz , D. and Thakral , K. K.Production of a corpus luteum angiogenic factor responsible for proliferation of capillaries and neovascularization of the corpus luteum . Proc. Natl. Acad. Sci. USA , 75 , 847 – 851 ( 1978. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3).Maiorana , A. and Guillino , P. M.Acquisition of angiogenic capacity and neoplastic transformation in the rat mammary gland . Cancer Res. , 38 , 4409 – 4414 ( 1978. ). [PubMed] [Google Scholar]
- 4).Forkman , J.Tumor angiogenesis: therapeutic implications . N. Engl. J. Med. , 18 , 1182 – 1183 ( 1971. ). [DOI] [PubMed] [Google Scholar]
- 5).Schor , A. M. and Schor , S. L.Tumor angiogenesis . J. Pathol. , 141 , 385 – 413 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 6).Taylor , S. and Folkman , J.Protamine is an inhibitor of angiogenesis . Nature , 297 , 307 – 312 ( 1982. ). [DOI] [PubMed] [Google Scholar]
- 7).Maione , T. E. , Gray , G. S. , Petro , J. , Hunt , A. J. , Donner , A. L. , Bauer , S. , Carson , H. F. and Sharpe , R. J.Inhibition of angiogenesis by recombinant human platelet factor‐4 and related peptides . Science , 257 , 77 – 79 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 8).Watanabe , N. , Niitsu , Y. , Umeno , H. , Kuriyama , H. , Neda , H. , Yamauchi , N. , Maeda , M. and Urushizaki , I.Toxic effect of tumor necrosis factor on tumor vasculature in mice . Cancer Res. , 48 , 2179 – 2183 ( 1988. ). [PubMed] [Google Scholar]
- 9).Sidky , Y. A. and Borden , E. C.Inhibition of angiogenesis by interferons: effect on tumor‐ and lymphocyte‐induced vascular responses . Cancer Res. , 47 , 5155 – 5161 ( 1987. ). [PubMed] [Google Scholar]
- 10).Nakamura , S. , Sakurada , S. , Salahuddin , Z. S. , Osada , Y. , Tanaka , G. N. , Sakamoto , N. , Sekiguchi , M. and Gallo , C. R.Inhibition of development of Kaposi's sarcomarelated lesions by a bacterial cell wall complex . Science , 13 , 1437 – 1440 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 11).Murata , J. , Saiki , I. , Nishimura , S. , Nishi , N. , Tokura , S. and Azuma , I.Inhibitory effect of chitin heparinoids on the lung metastasis of B16—BL6 melanoma . Jpn. J. Cancer Res. , 8 , 866 – 872 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12).Saiki , I. , Murata , J. , Nakajima , M. , Tokura , S. and Azuma , I.Inhibition by sulfated chitin derivatives of invasion through extracellular matrix and enzymatic degradation by metastatic melanoma cells . Cancer Res. , 50 , 3631 – 3637 ( 1990. ). [PubMed] [Google Scholar]
- 13).Murata , J. , Saiki , I. , Makabe , T. , Tsuta , Y. , Tokura , S. and Azuma , I.Inhibition of tumor‐induced angiogenesis by sulfated chitin derivatives . Cancer Res. , 51 , 22 – 26 ( 1991. ). [PubMed] [Google Scholar]
- 14).Saiki , I. , Murata , J. , Makabe , T. , Nishi , N. , Tokura , S. and Azuma , I.Inhibition of tumor angiogenesis by a synthetic cell‐adhesive polypeptide containing the Arg‐Gly‐Asp (RGD) sequence of fibronectin, poly(RGD) . Jpn. J. Cancer Res. , 81 , 668 – 675 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15).Morison , D. C. and Ryan , J. L.Endotoxins and disease mechanisms . Annu. Rev. Med. , 38 , 417 – 432 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 16).Havell , A. E. , Fiers , W. and North , J. R.The antitumor function of tumor necrosis factor (TNF) I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity . J. Exp. Med. , 167 , 1067 – 1085 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17).North , J. R. and Havell , A. E.The antitumor function of tumor necrosis factor (TNF) II. Analysis of the role of endogenous TNF in endotoxin‐induced hemorrhagic necrosis and regression of an established sarcoma . J. Exp. Med. , 167 , 1086 – 1099 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18).Kusama , T. , Soga , T. , Ono , Y. , Kumasawa , E. , Shioya , E. , Nakayama , K. , Uoto , K. and Osada , Y.Synthesis and biological activities of lipid A analogs: modification of a glycosidically bound group with chemically stable polar acidic groups and lipophilic groups on the disaccharide backbone with tetradecanoyl or N‐dodecanoylglycyl groups . Chem. Pharm. Bull. , 39 , 3244 – 3253 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 19).Kumazawa , E. , Tohgo , A. , Soga , T. , Kusama , T. and Osada , Y.Significant antitumor effect of a synthetic lipid A analogue, DT‐5461, on murine syngeneic tumor models . Cancer Immunol. Immunother. , 35 , 307 – 314 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20).Sato , K. , Saiki , I. , Yoo , Y. C. , Igarashi , Y. , Kiso , M. , Hasegawa , A. and Azuma , I.DT‐5461, a new synthetic lipid A analogue, inhibits lung and liver metastasis of tumor in mice . Jpn. J. Cancer Res. , 83 , 1081 – 1087 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21).Kreisl , R. A. and Ershler , W. B.Investigation of tumor angiogenesis in an i.d. mouse model: role of host interaction . J. Natl. Cancer Inst. , 80 , 849 – 854 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 22).Carsewell , E. A. , Old , L. T. , Kassel , R. L. , Green , S. , Fiore , N. and Willianson , B.An endotoxin‐induced serum factor that causes necrosis of tumors . Proc. Natl. Acad. Sci. USA , 72 , 3666 – 3670 ( 1975. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23).Blankenstein , T. , Qin , Z. , Uberla , K. , Muller , W. , Rosen , H. , Volk , H. D. and Diamantstein , T.Tumor suppression after tumor cell‐targeted tumor necrosis factor α gene transfer . J. Exp. Med. , 173 , 1047 – 1052 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24).Sato , N. , Goto , T. , Haranaka , K. , Satomi , N. , Nariuchi , H. , Mano‐Hirano , Y. and Sawasaki , Y.Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity . J. Natl. Cancer Inst. , 76 , 1113 – 1121 ( 1986. ). [PubMed] [Google Scholar]
- 25).Frater‐Schroder , M. , Risau , W. , Hallman , R. , Gautschi , P. and Bohlen , P.Tumor necrosis factor type α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo . Proc. Natl. Acad. Sci. USA , 84 , 5277 – 5281 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26).Yoshida , R. , Sato , K. , Yoo , Y. C. , Yoshimatsu , K. , Tamura , M. , Ishihara , C. , Arikawa , J. and Azuma , I.Effect of the synthetic lipid A‐related compound, DT‐5461, on resistance to Sendai virus infection in mice . Immunopharmacology , 28 , 153 – 161 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 27).Akimoto , T. , Kumazawa , E. , Jimbo , T. , Joto , N. and Tohgo , A.Antitumor effect of DT‐5461a, a synthetic low‐toxicity lipid A analog, involves endogenous tumor necrosis factor induction subsequent to macrophage activation . Int. J. Immunopharmacol. , 16 , 887 – 893 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 28).Denekamp , J.Vascular endothelium as the vulnerable element in tumors . Acta Oncol , 23 , 217 – 225 ( 1984. ). [DOI] [PubMed] [Google Scholar]
- 29).Fajardo , F. L. , Kwan , H. H. , Kowalski , J. , Prionas , D. S. and Allison , C. A.Dual role of tumor necrosis factor‐α in angiogenesis . Am. J. Pathol. , 140 , 539 – 544 ( 1992. ). [PMC free article] [PubMed] [Google Scholar]
- 30).Schultz , R. M. and Altom , G. M.Protective activity of recombinant murine tumor necrosis factor‐alpha and interferon‐gamma against experimental murine lung carcinoma metastases . J. Interferon Res. , 10 , 229 – 236 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 31).Orosz , P. , Echtenacher , B. , Falk , W. , Ruschoff , J. , Weber , D. , Crit , Rev. , Mannel , N. D.Enhancement of experimental metastasis by tumor necrosis factor . J. Exp. Med. , 177 , 1391 – 1398 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]